AMGN

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, April 29, 2023

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • When the true details entered the market, the lawsuit claims that investors suffered damages.
  • For more information on the SVB class action go to: https://bespc.com/cases/SIVB
    Amgen is one of the world’s largest independent biopharmaceutical companies.
  • On this news, the price of Amgen common stock fell by an additional 4.3%, further damaging investors.

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action – AMGN

Retrieved on: 
Saturday, April 29, 2023

WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than May 12, 2023.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

AMGN LAWSUIT ALERT: Levi & Korsinsky Reminds Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Friday, April 28, 2023

NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ("Amgen" or the "Company") (NASDAQ: AMGN) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ("Amgen" or the "Company") (NASDAQ: AMGN) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by alleged securities fraud.
  • This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 and April 27, 2022, inclusive.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

AMGN ALERT: The Klein Law Firm Reminds Investors of a Lead Plaintiff Deadline of May 12, 2023 in the Class Action Filed on Behalf of Amgen Inc. Shareholders

Retrieved on: 
Wednesday, April 26, 2023

NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Amgen Inc. (NASDAQ: AMGN) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Amgen Inc. (NASDAQ: AMGN) alleging that the Company violated federal securities laws.
  • This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 and April 27, 2022, inclusive.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
  • HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the AMGN lawsuit, please contact J. Klein, Esq.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMGN

Retrieved on: 
Tuesday, April 25, 2023

WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Amgen class action, go to https://rosenlegal.com/submit-form/?case_id=13114 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Amgen Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Amgen Inc. of Deadline in Securities Fraud Class Action Lawsuit

Retrieved on: 
Tuesday, April 25, 2023

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. (“Amgen”) ( NASDAQ: AMGN ).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. (“Amgen”) ( NASDAQ: AMGN ).
  • The action charges Amgen with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Amgen’s materially misleading statements and omissions to the public, Amgen’s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Amgen investors who have suffered significant losses to contact the firm directly to acquire more information.

AMGN LAWSUIT ALERT: Levi & Korsinsky Reminds Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Monday, April 24, 2023

NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ("Amgen" or the "Company") (NASDAQ: AMGN) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ("Amgen" or the "Company") (NASDAQ: AMGN) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by alleged securities fraud.
  • This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 and April 27, 2022, inclusive.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN

Retrieved on: 
Monday, April 24, 2023

NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN).

Key Points: 
  • NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Amgen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc. (AMGN) Investors of Class Action and to Actively Participate

Retrieved on: 
Monday, April 24, 2023

Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/amgn .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/amgn .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

AMGN Announcement: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Amgen Inc.

Retrieved on: 
Monday, April 24, 2023

RADNOR, Pa., April 23, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. (“Amgen”) ( NASDAQ: AMGN ).

Key Points: 
  • RADNOR, Pa., April 23, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. (“Amgen”) ( NASDAQ: AMGN ).
  • The action charges Amgen with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Amgen investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.